Updated May. 16, 2013 at 5:35 a.m.

Premium Lock New drug model? Quintiles to develop compounds with Merck Serono

Published: 2013-05-15 13:09:00
Updated: 2013-05-16 05:35:47

Print this blog post
Drug deal Drug deal

Fresh off an IPO that produced $1 billion for investors and the company, Quintiles on Wednesday announced a drug development deal in which it will work with Germany-based Merck Serono. But this contract is much different from others in which Quintiles shared some of the financial risk for new drug development. WRALTechWire Insiders get the story beyond the press release....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science